The final report from the Review Committee on the Regulation of Pharmaceutical Products calls for tighter regulation on drug supply in Hong Kong.

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1285, 2010-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of European Pharmaceutical Price Regulation on Generic Price Competition: A Review

By Puig-Junoy Jaume  

PharmacoEconomics, Vol. 28, Iss. 8, 2010-08 ,pp. : 649-663

Adis International

Access to resources Recommend Favorite

Difficulties in the Production of Identical Drug Products from a Pharmaceutical Technology Viewpoint

By Genazzani Armando A.   Pattarino Franco  

Drugs in R&D, Vol. 9, Iss. 2, 2008-01 ,pp. : 65-72

Adis International

Access to resources Recommend Favorite

Pharmaceutical development of microbicide drug products

By Friend David R.  

Pharmaceutical Development and Technology, Vol. 15, Iss. 6, 2010-12 ,pp. : 562-581

Informa Healthcare

Access to resources Recommend Favorite

A Review of: “Statistical Thinking for Non-Statisticians in Drug Regulation, by R. Kay”

By Dhar Sunil  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 1, 2009-01 ,pp. : 220-222

Taylor & Francis Ltd

Access to resources Recommend Favorite

Regulation of Drug Metabolism and Transporters

By  

Current Drug Metabolism, Vol. 10, Iss. 8, 2009-10 ,pp. : 932-945

Bentham Science Publishers

Access to resources Recommend Favorite